Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Identification of 4-Amino-Thieno[2,3-d]Pyrimidines as QcrB Inhibitors in Mycobacterium tuberculosis.

Harrison GA, Mayer Bridwell AE, Singh M, Jayaraman K, Weiss LA, Kinsella RL, Aneke JS, Flentie K, Schene ME, Gaggioli M, Solomon SD, Wildman SA, Meyers MJ, Stallings CL.

mSphere. 2019 Sep 11;4(5). pii: e00606-19. doi: 10.1128/mSphere.00606-19.

2.

Editorial overview: Attrition warfare: host cell weapons against intracellular pathogens, and how the pathogens fight back.

Stallings CL, Glickman MS.

Curr Opin Immunol. 2019 Oct;60:vi-ix. doi: 10.1016/j.coi.2019.07.009. Epub 2019 Aug 27. No abstract available.

PMID:
31471114
3.

A promising bioconjugate vaccine against hypervirulent Klebsiella pneumoniae.

Feldman MF, Mayer Bridwell AE, Scott NE, Vinogradov E, McKee SR, Chavez SM, Twentyman J, Stallings CL, Rosen DA, Harding CM.

Proc Natl Acad Sci U S A. 2019 Sep 10;116(37):18655-18663. doi: 10.1073/pnas.1907833116. Epub 2019 Aug 27.

4.

CarD contributes to diverse gene expression outcomes throughout the genome of Mycobacterium tuberculosis.

Zhu DX, Garner AL, Galburt EA, Stallings CL.

Proc Natl Acad Sci U S A. 2019 Jul 2;116(27):13573-13581. doi: 10.1073/pnas.1900176116. Epub 2019 Jun 19.

PMID:
31217290
5.

CarD and RbpA modify the kinetics of initial transcription and slow promoter escape of the Mycobacterium tuberculosis RNA polymerase.

Jensen D, Manzano AR, Rammohan J, Stallings CL, Galburt EA.

Nucleic Acids Res. 2019 Jul 26;47(13):6685-6698. doi: 10.1093/nar/gkz449.

6.

Chemical disarming of isoniazid resistance in Mycobacterium tuberculosis.

Flentie K, Harrison GA, Tükenmez H, Livny J, Good JAD, Sarkar S, Zhu DX, Kinsella RL, Weiss LA, Solomon SD, Schene ME, Hansen MR, Cairns AG, Kulén M, Wixe T, Lindgren AEG, Chorell E, Bengtsson C, Krishnan KS, Hultgren SJ, Larsson C, Almqvist F, Stallings CL.

Proc Natl Acad Sci U S A. 2019 May 21;116(21):10510-10517. doi: 10.1073/pnas.1818009116. Epub 2019 May 6.

PMID:
31061116
7.

A platform for glycoengineering a polyvalent pneumococcal bioconjugate vaccine using E. coli as a host.

Harding CM, Nasr MA, Scott NE, Goyette-Desjardins G, Nothaft H, Mayer AE, Chavez SM, Huynh JP, Kinsella RL, Szymanski CM, Stallings CL, Segura M, Feldman MF.

Nat Commun. 2019 Feb 21;10(1):891. doi: 10.1038/s41467-019-08869-9.

8.

The stringent response and Mycobacterium tuberculosis pathogenesis.

Prusa J, Zhu DX, Stallings CL.

Pathog Dis. 2018 Jul 1;76(5). doi: 10.1093/femspd/fty054. Review.

PMID:
29947752
9.

Bhlhe40 is an essential repressor of IL-10 during Mycobacterium tuberculosis infection.

Huynh JP, Lin CC, Kimmey JM, Jarjour NN, Schwarzkopf EA, Bradstreet TR, Shchukina I, Shpynov O, Weaver CT, Taneja R, Artyomov MN, Edelson BT, Stallings CL.

J Exp Med. 2018 Jul 2;215(7):1823-1838. doi: 10.1084/jem.20171704. Epub 2018 May 17.

10.

Domains within RbpA Serve Specific Functional Roles That Regulate the Expression of Distinct Mycobacterial Gene Subsets.

Prusa J, Jensen D, Santiago-Collazo G, Pope SS, Garner AL, Miller JJ, Ruiz Manzano A, Galburt EA, Stallings CL.

J Bacteriol. 2018 Jun 11;200(13). pii: e00690-17. doi: 10.1128/JB.00690-17. Print 2018 Jul 1.

11.

Irg1 expression in myeloid cells prevents immunopathology during M. tuberculosis infection.

Nair S, Huynh JP, Lampropoulou V, Loginicheva E, Esaulova E, Gounder AP, Boon ACM, Schwarzkopf EA, Bradstreet TR, Edelson BT, Artyomov MN, Stallings CL, Diamond MS.

J Exp Med. 2018 Apr 2;215(4):1035-1045. doi: 10.1084/jem.20180118. Epub 2018 Mar 6.

12.

LysMD3 is a type II membrane protein without an in vivo role in the response to a range of pathogens.

Yokoyama CC, Baldridge MT, Leung DW, Zhao G, Desai C, Liu TC, Diaz-Ochoa VE, Huynh JP, Kimmey JM, Sennott EL, Hole CR, Idol RA, Park S, Storek KM, Wang C, Hwang S, Viehmann Milam A, Chen E, Kerrinnes T, Starnbach MN, Handley SA, Mysorekar IU, Allen PM, Monack DM, Dinauer MC, Doering TL, Tsolis RM, Dworkin JE, Stallings CL, Amarasinghe GK, Micchelli CA, Virgin HW.

J Biol Chem. 2018 Apr 20;293(16):6022-6038. doi: 10.1074/jbc.RA117.001246. Epub 2018 Mar 1.

13.

blaIMP-27 on transferable plasmids in Proteus mirabilis and Providencia rettgeri.

Potter RF, Wallace MA, McMullen AR, Prusa J, Stallings CL, Burnham CAD, Dantas G.

Clin Microbiol Infect. 2018 Sep;24(9):1019.e5-1019.e8. doi: 10.1016/j.cmi.2018.02.018. Epub 2018 Mar 1.

14.

Roles for Autophagy Proteins in Immunity and Host Defense.

Kinsella RL, Nehls EM, Stallings CL.

Vet Pathol. 2018 May;55(3):366-373. doi: 10.1177/0300985818754967. Epub 2018 Feb 12. Review.

PMID:
29433400
15.

Rv0004 is a new essential member of the mycobacterial DNA replication machinery.

Mann KM, Huang DL, Hooppaw AJ, Logsdon MM, Richardson K, Lee HJ, Kimmey JM, Aldridge BB, Stallings CL.

PLoS Genet. 2017 Nov 27;13(11):e1007115. doi: 10.1371/journal.pgen.1007115. eCollection 2017 Nov.

16.

Host response: Inflammation promotes TB growth.

Stallings CL.

Nat Microbiol. 2017 Jun 27;2:17102. doi: 10.1038/nmicrobiol.2017.102. No abstract available.

PMID:
28653684
17.

Synthetic (p)ppGpp Analogue Is an Inhibitor of Stringent Response in Mycobacteria.

Syal K, Flentie K, Bhardwaj N, Maiti K, Jayaraman N, Stallings CL, Chatterji D.

Antimicrob Agents Chemother. 2017 May 24;61(6). pii: e00443-17. doi: 10.1128/AAC.00443-17. Print 2017 Jun.

18.

The impact of ISGylation during Mycobacterium tuberculosis infection in mice.

Kimmey JM, Campbell JA, Weiss LA, Monte KJ, Lenschow DJ, Stallings CL.

Microbes Infect. 2017 Apr - May;19(4-5):249-258. doi: 10.1016/j.micinf.2016.12.006. Epub 2017 Jan 10.

19.

Effects of Increasing the Affinity of CarD for RNA Polymerase on Mycobacterium tuberculosis Growth, rRNA Transcription, and Virulence.

Garner AL, Rammohan J, Huynh JP, Onder LM, Chen J, Bae B, Jensen D, Weiss LA, Manzano AR, Darst SA, Campbell EA, Nickels BE, Galburt EA, Stallings CL.

J Bacteriol. 2017 Jan 30;199(4). pii: e00698-16. doi: 10.1128/JB.00698-16. Print 2017 Feb 15.

20.

Bacterial Pathogens versus Autophagy: Implications for Therapeutic Interventions.

Kimmey JM, Stallings CL.

Trends Mol Med. 2016 Dec;22(12):1060-1076. doi: 10.1016/j.molmed.2016.10.008. Epub 2016 Nov 17. Review.

21.

Analysis of the contribution of MTP and the predicted Flp pilus genes to Mycobacterium tuberculosis pathogenesis.

Mann KM, Pride AC, Flentie K, Kimmey JM, Weiss LA, Stallings CL.

Microbiology. 2016 Oct;162(10):1784-1796. doi: 10.1099/mic.0.000368. Epub 2016 Aug 31.

22.

Cooperative stabilization of Mycobacterium tuberculosis rrnAP3 promoter open complexes by RbpA and CarD.

Rammohan J, Ruiz Manzano A, Garner AL, Prusa J, Stallings CL, Galburt EA.

Nucleic Acids Res. 2016 Sep 6;44(15):7304-13. doi: 10.1093/nar/gkw577. Epub 2016 Jun 24.

23.

Mycobacterium tuberculosis Transcription Machinery: Ready To Respond to Host Attacks.

Flentie K, Garner AL, Stallings CL.

J Bacteriol. 2016 Apr 14;198(9):1360-73. doi: 10.1128/JB.00935-15. Print 2016 May. Review.

24.

Plasmodium IspD (2-C-Methyl-D-erythritol 4-Phosphate Cytidyltransferase), an Essential and Druggable Antimalarial Target.

Imlay LS, Armstrong CM, Masters MC, Li T, Price KE, Edwards RL, Mann KM, Li LX, Stallings CL, Berry NG, O'Neill PM, Odom AR.

ACS Infect Dis. 2015 Apr 10;1(4):157-167. Epub 2015 Mar 2.

25.

Unique role for ATG5 in neutrophil-mediated immunopathology during M. tuberculosis infection.

Kimmey JM, Huynh JP, Weiss LA, Park S, Kambal A, Debnath J, Virgin HW, Stallings CL.

Nature. 2015 Dec 24;528(7583):565-9. doi: 10.1038/nature16451. Epub 2015 Dec 9.

26.

Characterization of phthiocerol and phthiodiolone dimycocerosate esters of M. tuberculosis by multiple-stage linear ion-trap MS.

Flentie KN, Stallings CL, Turk J, Minnaard AJ, Hsu FF.

J Lipid Res. 2016 Jan;57(1):142-55. doi: 10.1194/jlr.D063735. Epub 2015 Nov 16.

27.

The Cytosolic Sensor cGAS Detects Mycobacterium tuberculosis DNA to Induce Type I Interferons and Activate Autophagy.

Watson RO, Bell SL, MacDuff DA, Kimmey JM, Diner EJ, Olivas J, Vance RE, Stallings CL, Virgin HW, Cox JS.

Cell Host Microbe. 2015 Jun 10;17(6):811-819. doi: 10.1016/j.chom.2015.05.004. Epub 2015 Jun 2.

28.

CarD stabilizes mycobacterial open complexes via a two-tiered kinetic mechanism.

Rammohan J, Ruiz Manzano A, Garner AL, Stallings CL, Galburt EA.

Nucleic Acids Res. 2015 Mar 31;43(6):3272-85. doi: 10.1093/nar/gkv078. Epub 2015 Feb 19.

29.

Phenotypic complementation of genetic immunodeficiency by chronic herpesvirus infection.

MacDuff DA, Reese TA, Kimmey JM, Weiss LA, Song C, Zhang X, Kambal A, Duan E, Carrero JA, Boisson B, Laplantine E, Israel A, Picard C, Colonna M, Edelson BT, Sibley LD, Stallings CL, Casanova JL, Iwai K, Virgin HW.

Elife. 2015 Jan 20;4. doi: 10.7554/eLife.04494.

31.

CarD integrates three functional modules to promote efficient transcription, antibiotic tolerance, and pathogenesis in mycobacteria.

Garner AL, Weiss LA, Manzano AR, Galburt EA, Stallings CL.

Mol Microbiol. 2014 Aug;93(4):682-97. doi: 10.1111/mmi.12681. Epub 2014 Jul 16.

32.

Unexpected role for IL-17 in protective immunity against hypervirulent Mycobacterium tuberculosis HN878 infection.

Gopal R, Monin L, Slight S, Uche U, Blanchard E, Fallert Junecko BA, Ramos-Payan R, Stallings CL, Reinhart TA, Kolls JK, Kaushal D, Nagarajan U, Rangel-Moreno J, Khader SA.

PLoS Pathog. 2014 May 15;10(5):e1004099. doi: 10.1371/journal.ppat.1004099. eCollection 2014 May.

33.

Essential roles for Mycobacterium tuberculosis Rel beyond the production of (p)ppGpp.

Weiss LA, Stallings CL.

J Bacteriol. 2013 Dec;195(24):5629-38. doi: 10.1128/JB.00759-13. Epub 2013 Oct 11.

34.

Structure and function of CarD, an essential mycobacterial transcription factor.

Srivastava DB, Leon K, Osmundson J, Garner AL, Weiss LA, Westblade LF, Glickman MS, Landick R, Darst SA, Stallings CL, Campbell EA.

Proc Natl Acad Sci U S A. 2013 Jul 30;110(31):12619-24. doi: 10.1073/pnas.1308270110. Epub 2013 Jul 15.

35.

Compensatory dendritic cell development mediated by BATF-IRF interactions.

Tussiwand R, Lee WL, Murphy TL, Mashayekhi M, KC W, Albring JC, Satpathy AT, Rotondo JA, Edelson BT, Kretzer NM, Wu X, Weiss LA, Glasmacher E, Li P, Liao W, Behnke M, Lam SS, Aurthur CT, Leonard WJ, Singh H, Stallings CL, Sibley LD, Schreiber RD, Murphy KM.

Nature. 2012 Oct 25;490(7421):502-7. doi: 10.1038/nature11531. Epub 2012 Sep 19.

36.

Interaction of CarD with RNA polymerase mediates Mycobacterium tuberculosis viability, rifampin resistance, and pathogenesis.

Weiss LA, Harrison PG, Nickels BE, Glickman MS, Campbell EA, Darst SA, Stallings CL.

J Bacteriol. 2012 Oct;194(20):5621-31. Epub 2012 Aug 17.

37.

Catalytic and non-catalytic roles for the mono-ADP-ribosyltransferase Arr in the mycobacterial DNA damage response.

Stallings CL, Chu L, Li LX, Glickman MS.

PLoS One. 2011;6(7):e21807. doi: 10.1371/journal.pone.0021807. Epub 2011 Jul 18.

38.

CarD: a new RNA polymerase modulator in mycobacteria.

Stallings CL, Glickman MS.

Transcription. 2011 Jan-Feb;2(1):15-8. doi: 10.4161/trns.2.1.13628. Review.

39.

An improved counterselectable marker system for mycobacterial recombination using galK and 2-deoxy-galactose.

Barkan D, Stallings CL, Glickman MS.

Gene. 2011 Jan 1;470(1-2):31-6. doi: 10.1016/j.gene.2010.09.005. Epub 2010 Sep 17.

40.

Is Mycobacterium tuberculosis stressed out? A critical assessment of the genetic evidence.

Stallings CL, Glickman MS.

Microbes Infect. 2010 Dec;12(14-15):1091-101. doi: 10.1016/j.micinf.2010.07.014. Epub 2010 Aug 5. Review.

41.

CarD is an essential regulator of rRNA transcription required for Mycobacterium tuberculosis persistence.

Stallings CL, Stephanou NC, Chu L, Hochschild A, Nickels BE, Glickman MS.

Cell. 2009 Jul 10;138(1):146-59. doi: 10.1016/j.cell.2009.04.041.

42.

Unusual presentation of ovarian cellular fibroma coexisting with nodular sclerosing Hodgkin's disease: a case report and review of the literature.

Stallings CL, Shehata BM, Wang J, Chang TS, Ricketts RR.

J Pediatr Surg. 2008 Sep;43(9):1722-5. doi: 10.1016/j.jpedsurg.2008.04.019. Review.

PMID:
18779014
43.

Posttranslational modification and cell type-specific degradation of varicella-zoster virus ORF29p.

Stallings CL, Silverstein SJ.

J Virol. 2006 Nov;80(21):10836-46. Epub 2006 Sep 6.

44.

The cellular localization pattern of Varicella-Zoster virus ORF29p is influenced by proteasome-mediated degradation.

Stallings CL, Duigou GJ, Gershon AA, Gershon MD, Silverstein SJ.

J Virol. 2006 Feb;80(3):1497-512.

45.

Supplemental Content

Loading ...
Support Center